
Sign up to save your podcasts
Or


Every system we have followed so far — metabolism, repair, synthesis, signalling — depends on a deeper question being answered first: should this gene speak at all?
In this closing episode, Medlock Holmes confronts the highest tier of biochemical control: the regulation of gene expression. Here, information is not merely processed or executed — it is permitted. Transcription factors, epigenetic marks, enhancers, repressors, and chromatin remodellers collaborate to decide when a gene is accessible, when it is restrained, and when it is silenced entirely.
Drawing on the integrative perspective of Lehninger Principles of Biochemistry and the clinically grounded exploration of gene regulation in Harper’s Illustrated Biochemistry, this episode reveals that regulation is layered, redundant, and deeply contextual. The same genome gives rise to neurons, hepatocytes, muscle fibres — not because the code differs, but because access is selectively granted.
Medlock learns that disease at this level is rarely loud. It is subtle, persistent, and difficult to trace. Cancer, developmental disorders, and many chronic conditions emerge not from broken genes, but from misregulated ones — genes expressed at the wrong time, in the wrong place, or not at all.
The investigation ends where responsibility is greatest.Not with chemistry.Not with energy.But with choice.
Key Topics Explored
* Transcriptional regulation and transcription factors
* Enhancers, silencers, and combinatorial control
* Epigenetic modification and chromatin remodelling
* Cell-type–specific gene expression
* Developmental and environmental regulation
* Clinical relevance: cancer, imprinting disorders, epigenetic disease
By From the Medlock Holmes desk — where clinical questions are taken seriously.Every system we have followed so far — metabolism, repair, synthesis, signalling — depends on a deeper question being answered first: should this gene speak at all?
In this closing episode, Medlock Holmes confronts the highest tier of biochemical control: the regulation of gene expression. Here, information is not merely processed or executed — it is permitted. Transcription factors, epigenetic marks, enhancers, repressors, and chromatin remodellers collaborate to decide when a gene is accessible, when it is restrained, and when it is silenced entirely.
Drawing on the integrative perspective of Lehninger Principles of Biochemistry and the clinically grounded exploration of gene regulation in Harper’s Illustrated Biochemistry, this episode reveals that regulation is layered, redundant, and deeply contextual. The same genome gives rise to neurons, hepatocytes, muscle fibres — not because the code differs, but because access is selectively granted.
Medlock learns that disease at this level is rarely loud. It is subtle, persistent, and difficult to trace. Cancer, developmental disorders, and many chronic conditions emerge not from broken genes, but from misregulated ones — genes expressed at the wrong time, in the wrong place, or not at all.
The investigation ends where responsibility is greatest.Not with chemistry.Not with energy.But with choice.
Key Topics Explored
* Transcriptional regulation and transcription factors
* Enhancers, silencers, and combinatorial control
* Epigenetic modification and chromatin remodelling
* Cell-type–specific gene expression
* Developmental and environmental regulation
* Clinical relevance: cancer, imprinting disorders, epigenetic disease